搜索





搜索





市场行情
/
股票
/
hrmy
/

Harmony Biosciences Holdings Inc

HRMY

添加自选

35.760USD

-0.250-0.69%

收盘 07-28 16:00（美东）报价延迟15分钟

2.07B总市值

14.15市盈率 TTM

Harmony Biosciences Holdings Inc

35.760

-0.250-0.69%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

HRMY 利润表

您可以在这里找到Harmony Biosciences Holdings Inc的年度或季度收入报告，以深入了解Harmony Biosciences Holdings Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业总收入

16.59%215.39M

21.12%243.78M

28.71%239.46M

16.01%200.49M

19.48%184.73M

19.51%201.27M

16.08%186.04M

28.76%172.81M

29.79%154.62M

31.26%168.41M

36.74%160.27M

25.40%134.22M

39.63%119.13M

40.67%128.31M

45.18%117.21M

44.98%107.03M

42.97%85.31M

62.05%91.21M

77.01%80.73M

94.24%73.82M

200.78%59.67M

--56.29M

--45.61M

--38.01M

--19.84M

营业收入

16.59%215.39M

21.12%243.78M

28.71%239.46M

16.01%200.49M

19.48%184.73M

19.51%201.27M

16.08%186.04M

28.76%172.81M

29.79%154.62M

31.26%168.41M

36.74%160.27M

25.40%134.22M

39.63%119.13M

40.67%128.31M

45.18%117.21M

44.98%107.03M

42.97%85.31M

62.05%91.21M

77.01%80.73M

94.24%73.82M

200.78%59.67M

--56.29M

--45.61M

--38.01M

--19.84M

主营业务成本

39.13%44.51M

25.98%68.55M

39.44%59.65M

18.69%38.15M

16.41%31.99M

26.09%54.41M

32.46%42.78M

28.53%32.14M

32.26%27.48M

60.51%43.15M

40.67%32.30M

32.17%25.01M

41.21%20.78M

50.90%26.89M

57.21%22.96M

49.14%18.92M

41.38%14.72M

79.64%17.82M

85.10%14.60M

96.51%12.69M

199.63%10.41M

--9.92M

--7.89M

--6.46M

--3.47M

营业费用

13.70%146.10M

41.01%205.22M

39.93%173.97M

13.36%152.31M

25.25%128.49M

13.51%145.54M

29.83%124.33M

53.88%134.36M

30.34%102.58M

58.89%128.22M

-9.07%95.76M

18.13%87.31M

36.27%78.70M

28.94%80.69M

76.45%105.31M

46.33%73.91M

27.95%57.76M

28.96%62.58M

69.40%59.68M

70.93%50.51M

53.29%45.14M

--48.53M

--35.23M

--29.55M

--29.45M

研发费用

8.23%37.38M

44.04%49.93M

116.50%54.96M

7.90%50.16M

55.66%34.54M

14.39%34.67M

45.08%25.39M

210.56%46.49M

66.97%22.19M

200.30%30.31M

-56.84%17.50M

18.16%14.97M

75.36%13.29M

35.44%10.09M

245.41%40.55M

94.95%12.67M

61.96%7.58M

-2.21%7.45M

177.52%11.74M

55.86%6.50M

36.37%4.68M

--7.62M

--4.23M

--4.17M

--3.43M

折旧摊销及损耗

0.00%5.97M

24.53%7.43M

0.00%5.97M

-1.40%5.97M

-2.55%5.97M

-2.56%5.97M

-2.26%5.97M

-0.20%6.05M

0.99%6.12M

0.94%6.13M

0.71%6.11M

0.15%6.06M

16.64%6.06M

27.48%6.07M

29.77%6.06M

28.04%6.05M

11.11%5.20M

8.60%4.76M

137.52%4.67M

135.98%4.73M

148.49%4.68M

--4.38M

--1.97M

--2.00M

--1.88M

营业利润

23.19%69.29M

-30.81%38.56M

6.12%65.49M

25.30%48.18M

8.09%56.24M

38.64%55.73M

-4.34%61.71M

-18.02%38.45M

28.72%52.03M

-15.58%40.20M

442.05%64.51M

41.63%46.90M

46.69%40.42M

66.30%47.61M

-43.47%11.90M

42.06%33.12M

89.61%27.56M

269.05%28.63M

102.82%21.05M

175.72%23.31M

251.24%14.53M

--7.76M

--10.38M

--8.46M

---9.61M

净非营业利息收入（费用）

利息收入

14.14%5.76M

30.76%5.85M

16.18%5.73M

12.56%5.30M

13.91%5.04M

-69.61%4.48M

--4.93M

--4.71M

--4.43M

--14.73M

----

利息费用

-15.99%3.08M

-16.11%3.39M

-17.06%3.46M

-17.62%3.48M

-15.73%3.67M

-66.84%4.04M

--4.17M

--4.23M

--4.36M

--12.18M

----

出售证券收益

9.04%-151.00K

7.10%-157.00K

8.57%-160.00K

7.39%-163.00K

7.78%-166.00K

94.79%-169.00K

---175.00K

---176.00K

---180.00K

---3.25M

----

特殊收入（费用）

---32.00M

----

100.00%0.00

---17.09M

----

--0.00

---9.77M

----

--0.00

100.00%0.00

----

--0.00

---26.15M

----

--0.00

---22.64M

其他非经营性收入（费用）

53.99%-127.00K

-165.63%-105.00K

14.52%-106.00K

-621.62%-193.00K

-95.74%-276.00K

-17.10%160.00K

-2380.00%-124.00K

219.35%37.00K

-7150.00%-141.00K

164.38%193.00K

-108.93%-5.00K

-173.81%-31.00K

200.00%2.00K

135.48%73.00K

--56.00K

950.00%42.00K

90.00%-2.00K

--31.00K

----

100.26%4.00K

---20.00K

--0.00

---1.52M

---1.55M

--0.00

税前利润

-30.59%39.69M

-27.42%40.76M

8.56%67.49M

128.81%49.64M

10.41%57.18M

41.49%56.16M

19.95%62.17M

-50.80%21.69M

37.07%51.78M

-10.01%39.69M

550.58%51.83M

50.85%44.09M

61.56%37.78M

80.20%44.10M

175.72%7.97M

81.68%29.23M

216.61%23.39M

11866.83%24.48M

-651.18%-10.52M

59688.89%16.09M

119.12%7.39M

---208.00K

--1.91M

---27.00K

---38.62M

所得税

-38.03%7.20M

173.56%18.27M

3.41%16.63M

-2.40%9.86M

-13.63%11.62M

-48.94%6.68M

20.24%16.08M

3.14%10.10M

62.16%13.45M

396.91%13.08M

116.72%13.37M

71.84%9.79M

336.58%8.29M

-350.20%-4.41M

-8766.52%-79.98M

189.05%5.70M

--1.90M

--1.76M

---902.00K

--1.97M

--0.00

除税后利润

-28.69%32.49M

-54.55%22.49M

10.35%50.87M

243.16%39.78M

18.85%45.56M

85.95%49.48M

19.84%46.09M

-66.21%11.59M

30.01%38.33M

-45.15%26.61M

-56.27%38.46M

45.77%34.30M

37.24%29.48M

113.56%48.51M

1014.17%87.94M

66.69%23.53M

190.89%21.48M

11020.19%22.71M

-603.93%-9.62M

52385.19%14.12M

119.12%7.39M

---208.00K

--1.91M

---27.00K

---38.62M

持续经营利润

-28.69%32.49M

-54.55%22.49M

10.35%50.87M

243.16%39.78M

18.85%45.56M

85.95%49.48M

19.84%46.09M

-66.21%11.59M

30.01%38.33M

-45.15%26.61M

-56.27%38.46M

45.77%34.30M

37.24%29.48M

113.56%48.51M

1014.17%87.94M

66.69%23.53M

190.89%21.48M

11020.19%22.71M

-603.93%-9.62M

52385.19%14.12M

119.12%7.39M

---208.00K

--1.91M

---27.00K

---38.62M

归属于母公司的净利润

-28.69%32.49M

-54.55%22.49M

10.35%50.87M

243.16%39.78M

18.85%45.56M

85.95%49.48M

19.84%46.09M

-66.21%11.59M

30.01%38.33M

-45.15%26.61M

-56.27%38.46M

45.77%34.30M

37.24%29.48M

113.56%48.51M

1014.17%87.94M

66.69%23.53M

190.89%21.48M

11020.19%22.71M

-134.41%-9.62M

234.79%14.12M

115.05%7.39M

---208.00K

---4.10M

---10.47M

---49.06M

优先股派息

----

--0.00

-100.00%0.00

--0.00

--6.01M

--10.45M

归属于普通股东的净利润

-28.69%32.49M

-54.55%22.49M

10.35%50.87M

243.16%39.78M

18.85%45.56M

85.95%49.48M

19.84%46.09M

-66.21%11.59M

30.01%38.33M

-45.15%26.61M

-56.27%38.46M

45.77%34.30M

37.24%29.48M

113.56%48.51M

1014.17%87.94M

66.69%23.53M

190.89%21.48M

11020.19%22.71M

-134.41%-9.62M

234.79%14.12M

115.05%7.39M

---208.00K

---4.10M

---10.47M

---49.06M

基本每股收益

-29.32%0.56

-54.48%0.39

9.05%0.88

239.17%0.69

17.73%0.79

89.89%0.87

26.15%0.81

-64.32%0.20

36.79%0.68

-44.10%0.46

-56.73%0.64

43.55%0.57

35.34%0.49

110.47%0.82

990.83%1.48

60.70%0.40

180.92%0.36

10697.27%0.39

-131.02%-0.17

252.08%0.25

116.91%0.13

--0.00

---0.07

---0.16

---0.77

稀释每股收益

-29.00%0.55

-54.35%0.39

9.20%0.87

237.96%0.68

16.97%0.78

87.84%0.85

25.16%0.79

-64.33%0.20

38.19%0.67

-42.53%0.45

-55.89%0.63

46.20%0.56

35.81%0.48

109.64%0.79

962.11%1.44

60.31%0.39

182.33%0.35

10359.29%0.38

-131.02%-0.17

247.79%0.24

116.36%0.13

--0.00

---0.07

---0.16

---0.77

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Harmony Biosciences Holdings Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 HRMY 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Harmony Biosciences Holdings Inc 财年末的营收是多少？



Harmony Biosciences Holdings Inc 2025 财年营收为 868.45M，高于上一财年的714.73M。

Harmony Biosciences Holdings Inc 最近一个季度的营收是多少？



Harmony Biosciences Holdings Inc 最近一个季度的营收为 215.39M，同比增长 16.59%。

Harmony Biosciences Holdings Inc 全年的净利润是多少？



Harmony Biosciences Holdings Inc 2025 财年净利润为 158.69M。

Harmony Biosciences Holdings Inc 上一季度的净利润是多少？



Harmony Biosciences Holdings Inc 最近一个季度的净利润为 32.49M。

Harmony Biosciences Holdings Inc 年度营业利润是多少？



Harmony Biosciences Holdings Inc 2025 财年的营业利润为 208.47M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。